Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.430
-0.010 (-0.69%)
Apr 1, 2025, 10:38 AM EDT - Market open
Intelligent Bio Solutions Employees
Intelligent Bio Solutions had 50 employees as of June 30, 2024. The number of employees decreased by 1 or -1.96% compared to the previous year.
Employees
50
Change (1Y)
-1
Growth (1Y)
-1.96%
Revenue / Employee
$60,628
Profits / Employee
-$213,940
Market Cap
7.55M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INBS News
- 1 day ago - Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System - GlobeNewsWire
- 4 days ago - Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show - GlobeNewsWire
- 5 days ago - Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra - GlobeNewsWire
- 6 days ago - Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - GlobeNewsWire
- 7 days ago - Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch - GlobeNewsWire
- 12 days ago - Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant - GlobeNewsWire
- 21 days ago - Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock - GlobeNewsWire